Quick Takeaways
- This page summarizes Everett Rand Sutherland's Form 3 filing for Krystal Biotech, Inc. (KRYS).
- 0 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 26 Jan 2022, 15:56.
Everett Rand Sutherland - 18 Jan 2022 Form 3 Insider Report for Krystal Biotech, Inc. (KRYS)
- Role
- Director
- Signature
- /s/ Krish Krishnan, as Attorney-in-Fact
- Issuer symbol
- KRYS
- Transactions as of
- 18 Jan 2022
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 26 Jan 2022, 15:56:48 UTC
- Previous filing
- 14 Sep 2021
- Next filing
- 31 Jan 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Everett Rand Sutherland filed Form 3 for Krystal Biotech, Inc. (KRYS) on 26 Jan 2022."
What Changed
- Previous filing in this sequence was filed on 14 Sep 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Official SEC Source
See Original Filing
Ownership activity is grounded in SEC Form 3 disclosures.
No securities are beneficially owned.
Remarks:
Exhibit 24.1 - Power of Attorney